Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus

被引:8
|
作者
Crisman, Celina M. [1 ]
Patel, Ankur R. [2 ,3 ]
Winston, Graham [4 ]
Brennan, Cameron W. [2 ,3 ]
Tabar, Viviane [2 ,3 ]
Moss, Nelson S. [2 ,3 ]
机构
[1] UMass Mem Med Ctr, Dept Neurosurg, Worcester, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Brain Metastasis Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, New York, NY USA
基金
美国国家卫生研究院;
关键词
Choroid plexus; Intraventricular metastasis; Renal cell carcinoma; Stereotactic body radiotherapy; Stereotactic radiosurgery; BRAIN METASTASES; PROGNOSTIC-FACTORS; SURVIVAL; RADIOSURGERY; THERAPY;
D O I
10.1016/j.wneu.2020.03.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Intraventricular metastatic brain tumors account for a small, but challenging, fraction of metastatic brain tumors (0.9%-4.5%). Metastases from renal cell carcinoma (RCC) account for a large portion of these intraventricular tumors. Although patient outcomes have been assumed to be poor, these have not been reported in a modern series with a multimodality treatment paradigm of radiotherapy (RT), resection, and cerebrospinal fluid (CSF) diversion. We have presented the first case series of patients with intraventricular metastatic tumors from RCC. METHODS: We performed a single-institution retrospective review of patients with intraventricular RCC metastases treated from January 2003 to January 2019. Volumetric analysis was used to delineate the tumor size and the Kaplan-Meier method to evaluate the survival data. RESULTS: A total of 22 intraventricular RCC metastases were identified in 19 patients with 61.3 patient-years of follow-up. The median patient age was 64 years, and the median tumor volume was 2.2 cm(3). Overall, 19 metastases had been treated initially with RT. Of these, 16 had received stereotactic body RT and 3 had received whole brain RT. Three tumors were surgically excised and had received adjuvant stereotactic body RT in the upfront setting. Although 5 patients had presented with obstructive hydrocephalus, none had required CSF diversion. After treatment, 5 metastases had progressed, resulting in 1- and 3-year progression-free survival rates of 81.6% and 68%, respectively. The median overall survival was 2.8 years, with 1- and 5-year overall survival rates of 76.7% and 28.3%, respectively. Leptomeningeal carcinomatosis was not observed. CONCLUSIONS: Despite the relatively limited overall survival for this population with metastatic cancer, comparable to contemporary parenchymal brain metastasis cohorts, reasonable local central nervous system control was achieved in most patients using a paradigm of focal RT and resection, where indicated. Finally, CSF diversion was not required even in patients presenting with hydrocephalus.
引用
收藏
页码:E7 / E13
页数:7
相关论文
共 50 条
  • [41] Clinical outcomes of 168 Chinese patients after local surgery for bone metastases arising from advanced renal cell carcinoma
    Dong, Yi
    Wang, Zheng
    Lu, Xin
    Wu, Zhenjie
    Zhang, Zongqin
    Yu, Yongwei
    Peng, Fei
    Liu, Bing
    Wang, Linhui
    CANCER, 2020, 126 : 2079 - 2085
  • [42] The Impact of Radiotherapy Fields in the Treatment of Patients with Choroid Plexus Carcinoma
    Mazloom, A.
    Wolff, J.
    Paulino, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S510 - S510
  • [43] Outcomes of patients with brain metastases for melanoma and renal cell carcinoma primarily managed with stereotactic radiosurgery
    Jensen, Randy L.
    Shrieve, Dennis
    NEUROSURGERY, 2007, 61 (01) : 218 - 218
  • [44] Brain metastases in patients with renal cell carcinoma - Outcomes with systemic and local treatment in the modern era
    Bender, C.
    Delecluse, S.
    Seydel, F.
    Haag, G. M.
    Gruen, B.
    Koerber, S. A.
    Debus, J.
    Duensing, S.
    Hohenfellner, M.
    Zeier, M.
    Jaeger, D.
    Zschaebitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 207 - 207
  • [45] Outcomes of patients with metastatic renal cell carcinoma and bone metastases in the targeted-therapy era
    Kalra, Sarathi
    Verma, Jonathan
    Atkinson, Bradley J.
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Tamboli, Pheroze
    Sircar, Kanishka
    Rao, Priya
    Corn, Paul Gettys
    Tannir, Nizar M.
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [46] THE IMPACT OF RADIOTHERAPY FIELDS IN THE TREATMENT OF PATIENTS WITH CHOROID PLEXUS CARCINOMA
    Mazloom, Ali
    Wolff, Johannes E.
    Paulino, Arnold C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 79 - 84
  • [47] Shunt-related abdominal metastases in a child with choroid plexus carcinoma: Case report
    Donovan, D
    Prauner, RD
    NEUROSURGERY, 2005, 56 (02) : 412 - 412
  • [48] Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors
    Wrede, Brigitte
    Liu, Ping
    Wolff, Johannes Ernst Alexander
    JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (03) : 345 - 351
  • [49] Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
    Ma, Jennifer
    del Balzo, Luke
    Khaleel, Sari Safaa
    Flynn, Jessica
    Zhang, Zhigang
    Voss, Martin H.
    Freeman, Benjamin
    Hakimi, A. Ari
    Lee, Chung-Han
    Eichholz, Jordan
    Kelly, Daniel W.
    Yang, Jonathan T.
    Mueller, Boris
    Carlo, Maria Isabel
    Motzer, Robert J.
    Imber, Brandon S.
    Beal, Kathryn
    Moss, Nelson S.
    Kotecha, Ritesh
    Pike, Luke Roy George
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors
    Brigitte Wrede
    Ping Liu
    Johannes Ernst Alexander Wolff
    Journal of Neuro-Oncology, 2007, 85 : 345 - 351